![Peter Lipsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Lipsky active positions
Companies | Position | Start | End |
---|---|---|---|
AMPEL BioSolutions LLC
![]() AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Chief Tech/Sci/R&D Officer | 01/01/2013 | - |
Founder | 01/01/2013 | - |
Career history of Peter Lipsky
Statistics
International
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
AMPEL BioSolutions LLC
![]() AMPEL BioSolutions LLC BiotechnologyHealth Technology AMPEL BioSolutions LLC is a precision medicine company that develops and commercializes gene expression tests for blood or tissue samples. The private company is based in Charlottesville, VA, and has CRO capabilities. The company's tests provide clinical decision support by determining disease status, identifying molecular pathways, and predicting drug options. The company's technology is a cloud-based platform that hosts proprietary RNA analytic tools and machine learning algorithms. The company's precision medicine test portfolio covers various disease areas, including lupus, psoriasis, scleroderma, and lung cancer. The company was elected to the Coalition for 21st Century Precision Medicine in early 2022. AMPEL Biosolutions was founded in 2013 by Peter Lipsky and Amrie Grammer, and Peter Lipsky has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Peter Lipsky
- Experience